Search for: "Purdue Pharma L.P."
Results 41 - 60
of 124
Sorted by Relevance
|
Sort by Date
11 Jan 2011, 5:45 am
In May 2007, Purdue Frederick, a subsidiary of Purdue Pharma L.P., pleaded guilty to felony misbranding of its painkiller drug, Oxycontin, as part of a settlement with federal prosecutors. [read post]
11 Jan 2011, 5:45 am
In May 2007, Purdue Frederick, a subsidiary of Purdue Pharma L.P., pleaded guilty to felony misbranding of its painkiller drug, Oxycontin, as part of a settlement with federal prosecutors. [read post]
14 Jan 2024, 9:29 pm
Cir. 2023)Purdue Pharma L.P. v. [read post]
31 Mar 2010, 11:55 pm
Purdue Pharma, L.P., that a general release signed by a whistleblower upon accepting a severance package barred his qui tam action against his former employer, because the government was aware of the conduct he later alleged to be fraudulent. [read post]
27 Apr 2018, 9:22 am
Purdue Pharma L.P. et al., Civil Action No. 18-383-RGA (D.Del. [read post]
15 Nov 2023, 1:13 pm
Purdue Pharma L.P. [read post]
13 Mar 2024, 7:17 am
Ironically, the underlying Federal Circuit decision that Purdue sought to challenge, Purdue Pharma L.P. v. [read post]
7 Jan 2024, 9:59 pm
By Kevin E. [read post]
14 Feb 2019, 6:00 am
Purdue Pharma L.P., et al., C.A. [read post]
8 Feb 2016, 7:49 pm
Purdue Pharma L.P., the Fourth Circuit recently held that the pre-2010 public disclosure bar prohibits a subsequent relator from bringing a False Claims Act qui tam based upon “facts” that their counsel learned in representing a prior relator who brought a qui tam. [read post]
8 Feb 2016, 7:49 pm
Purdue Pharma L.P., the Fourth Circuit recently held that the pre-2010 public disclosure bar prohibits a subsequent relator from bringing a False Claims Act qui tam based upon “facts” that their counsel learned in representing a prior relator who brought a qui tam. [read post]
10 Jan 2013, 7:40 am
In a recent opinion, Purdue Pharma L.P. v. [read post]
16 Apr 2013, 8:36 pm
Purdue Pharma Prods. [read post]
18 Aug 2010, 12:19 am
and industrial applicability on 7 October: Eli Lilly & Co v Human Genome Sciences Inc (IPKat) Nuvigil (Armodafinil) – US: Cephalon and Mylan Pharmaceuticals agree to drop two patents from Nuvigil patent suit (Patent Docs) OxyContin (Oxycodone) – Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma L.P. et al. v. [read post]
21 Jul 2007, 3:36 am
Purdue Pharma L.P., its top lawyer and former president and former chief medical officer pleaded guilty in May to claiming to doctors that OxyContin was less addictive and less subject to abuse than other pain medications. [read post]
7 Dec 2011, 11:32 am
Purdue Pharma, L.P., 343 F. [read post]
30 Oct 2018, 4:12 pm
The increase in litigation during this past year resulted from civil disputes with a variety of corporations, from Purdue Pharma L.P. to Facebook. [read post]
21 Apr 2014, 7:53 pm
Purdue Pharma L.P., 737 F.3d 908 (4th Cir. 2013).As Mr. [read post]
12 Dec 2011, 7:24 am
A Penalty that Includes Career Death: The former top executives and general counsel of Purdue Pharma L.P. are fighting their 12-year ban on working in the health care and pharmaceutical industries. [read post]
13 May 2010, 4:58 pm
Kappos (Orange Book Blog) (FDA Law Blog) OxyContin (Oxycodone) – US: Patent infringement suit following a Paragraph IV certification: Purdue Pharma L.P. et al v. [read post]
